SCHEMBL21031204

SCHEMBL21031204

Cc1nc(-c2ccccc2)cc(-c2cccc(-c3cccc(-c4cccc(-c5cc(-c6ccccc6)nc(C)n5)c4)c3)c2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.53
MEN1 O00255 8/20 0.52
ALDH1A1 P00352 5/20 0.52
HPGD P15428 4/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
ADORA2A P29274 1/20 0.52
ADORA1 P30542 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
MAPT P10636 9/20 0.52
TDP1 Q9NUW8 2/20 0.52
TSHR P16473 2/20 0.52
ATM Q13315 1/20 0.52
LMNA P02545 4/20 0.52
KDM4E B2RXH2 4/20 0.52
TP53 P04637 4/20 0.51
POLB P06746 2/20 0.51
HSD17B10 Q99714 1/20 0.50
RAB9A P51151 2/20 0.48
PKM P14618 1/20 0.48
MAOA P21397 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12166264 0.98 KMT2A (0.51) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL21030901 0.96 KMT2A (0.53) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL12166272 0.96 KMT2A (0.49) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL12166284 0.94 KMT2A (0.47) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL18562524 0.94 KMT2A (0.55) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL23615528 0.93 MAPT (0.54) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL12166275 0.92 KMT2A (0.46) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL10039374 0.91 KMT2A (0.60) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL12188081 0.89 L3MBTL1 (0.62) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL17051653 0.88 KMT2A (0.53) KMT2AMEN1ALDH1A1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 KMT2A 1221/4885MEN1 3802/4885ALDH1A1 865/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 KMT2A 1221/4885MEN1 3802/4885ALDH1A1 865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.